Dr. Jagannath on CAR T-Cell Therapy for Multiple Myeloma

Sundar Jagannath, MD, director of the Multiple Myeloma program and professor of medicine at the Tisch Cancer Institute, Mount Sinai Cancer Center, discusses chimeric antigen receptor (CAR) T-cell therapy for patients with multiple myeloma.